Nadim J Ajami

32PUBLICATIONS
384CO-AUTHORS
Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 26, 2026
Colitis-Associated Colorectal Cancer-STAT3 Inhibition as a Preventive Strategy.

|Sep 22, 2026
The emerging role of microbiota in neuro-oncology.

|Jan 20, 2026
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD.

Christopher Fan, Tomo Hayase, Chia-Chi Chang

|Jan 10, 2026
Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier.

Margaux Robert, Satabdi Saha, Nazli Dizman

|Nov 24, 2025
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.

Agathe Carrier, Paolo Manghi, Carolina Alves Costa Silva

|Nov 14, 2025
Microbial signals in primary and metastatic brain tumors.

Golnaz Morad, Ashish V Damania, Brenda Melendez

Pageof 6

Frequent Collaborators

17 joint publications

Jennifer Wargo

7 joint publications

Michael A Davies

7 joint publications

Christine B Peterson

6 joint publications

P Andrew Futreal